Cheapest GLP-1 With Insurance in 2026: The Real Lowest-Cost Paths
Last verified: April 21, 2026 · Written and fact-checked by the Weight Loss Provider Guide research team
Affiliate disclosure: We may earn commissions from Ro and Sesame Care. Our picks are based on verified pricing, coverage fit, and FDA-approved status — not payout.

The cheapest GLP-1 with insurance is a path, not a product. Verified against FDA, CMS, and manufacturer sources, April 21, 2026.
Here’s the part nobody explains clearly: five FDA-approved GLP-1s can cost as little as $25/month with insurance — Wegovy, Zepbound, Ozempic, Mounjaro, and Foundayo. (A sixth, Rybelsus, also has a $25 path if you have type 2 diabetes and commercial coverage.) The cheapest GLP-1 with insurance isn’t a single drug. It’s a path. Which drug your plan actually covers, whether you stack the manufacturer savings card on top, and — the part most “cheapest” pages bury or skip — whether you already have an in-network doctor willing to write the script.
If you do, that’s your cheapest path. You don’t need us. You don’t need any telehealth membership. Your drug can drop as low as $25 per fill, your only extra cost is whatever your plan asks for at the office (copay, deductible, or coinsurance), and you can close this tab.
If you don’t — or your insurance is already dragging you through prior authorization hell — we’ll show you exactly where to go next. Everything below is the real breakdown: the verified cost stack for every FDA-approved GLP-1, the Zepbound annual savings cap that mid-year blows up the $25 number nobody else mentions, the three legitimate paths forward if your insurance says no, and exactly what changes on July 1, 2026 when Medicare’s GLP-1 Bridge goes live.
✅ What we actually verified for this page (April 21, 2026):
- • Wegovy, Ozempic, Rybelsus savings card terms pulled directly from NovoCare.
- • Zepbound, Mounjaro, Foundayo savings card terms from Lilly’s official savings pages and Foundayo.lilly.com/coverage-savings.
- • 2026 monthly and annual savings caps confirmed against manufacturer terms and conditions.
- • Medicare GLP-1 Bridge eligibility criteria confirmed from CMS.gov (page updated April 6, 2026).
- • Ro Body membership pricing and Insurance Coverage Checker mechanics confirmed at ro.co/weight-loss/pricing.
- • Medicaid obesity-coverage count (13 states) from the Kaiser Family Foundation’s January 2026 Medicaid GLP-1 tracker.
- • Employer coverage rates from Peterson-KFF Health System Tracker (2025 data).
The 30-Second Answer: What Is the Cheapest GLP-1 With Insurance?
The cheapest GLP-1 with insurance is an FDA-approved brand-name drug your plan already covers, stacked with the manufacturer’s savings card. For eligible commercially insured patients, that brings Wegovy, Zepbound (KwikPen), Ozempic, Mounjaro, or Foundayo to as little as $25/month. The winner depends on which of those five (or Rybelsus, if you have type 2 diabetes) is on your specific plan’s formulary — not which drug has the lowest list price.
“Cheapest GLP-1 with insurance” has one honest answer and three conditions that can change it:
Ro’s free Insurance Coverage Checker contacts your insurer on your behalf and sends you a personalized report covering your estimated copay and prior-authorization status per drug. No commitment required.
The Real Cost Ladder: Six Paths Compared by Route
Most “cheapest GLP-1” pages compare drug prices. That’s half the story. The total cost of getting a GLP-1 through insurance is the drug cost plus the extra fee layer — office copay, membership fee, visit fee, deductible, coinsurance, or prior-auth friction. This is where most pages lie to you by omission.
| Path | Drug Cost Floor |
|---|---|
| 1. Your in-network doctor | $25/mo (savings card, if plan covers) |
| 2. Ro (free coverage check + optional Body membership) | $25/mo if covered; $149–$449/mo cash pay if not |
| 3. Form Health | $25/mo if covered; $299/mo program fee if not covered |
| 4. WeightWatchers Med+ | $25/mo if covered (via savings card) |
| 5. PlushCare | $25/mo if covered |
| 6. Sesame Care | $25/mo if covered |
Primary sources: NovoCare, Zepbound Savings, Foundayo Savings, Ro Pricing
The honest read of this table
If your plan covers the drug and covers clinical visits and labs, Form Health’s insurance-billed model can be the cheapest telehealth route, because the bulk of what you pay is your normal cost-sharing. Form Health is not one of our affiliate partners — we’re including it because this page’s job is to show you the truth.
For most people without an existing prescriber or without confirmed plan coverage, Ro’s free coverage check is our honest first move. And here’s the damaging admission most affiliate pages hide: Ro does not have the cheapest membership on this list. PlushCare ($19.99/mo) and WeightWatchers Med+ ($74/mo ongoing after intro) both undercut Ro on monthly fee. If membership fee alone is your priority, go look at those.
But because Ro’s Insurance Coverage Checker is genuinely free to run, and because Ro’s insurance concierge files prior authorization paperwork for you if you do join, it’s the lowest-risk, highest-certainty first action for a commercial-insurance shopper who doesn’t already have a doctor handling this. You can check what your plan covers without committing to Ro’s $149/month membership — then decide where you actually want to go next.
How Much Does Each GLP-1 Actually Cost With Insurance in 2026?
With commercial insurance plus the manufacturer savings card, five FDA-approved GLP-1s hit a $25/month floor. Without that stack — or with government insurance — the numbers are very different. Below is the verified 2026 cost of every major FDA-approved GLP-1, including the caps and catches most pages skip.

Start with coverage clarity. Click to check which GLP-1s your plan covers — free, via Ro’s Insurance Coverage Checker. (Affiliate link.)
Wegovy (semaglutide)
Novo Nordisk · Weight loss, cardiovascular risk reduction, MASH
Source: NovoCare Wegovy Savings
Zepbound (tirzepatide)
Eli Lilly · Weight loss, obstructive sleep apnea
Source: Zepbound Savings Options
Ozempic (semaglutide)
Novo Nordisk · Type 2 diabetes; cardiovascular risk reduction in diabetic adults
Source: Ozempic Savings
Mounjaro (tirzepatide)
Eli Lilly · Type 2 diabetes
Source: Lilly Mounjaro Savings & Support
Foundayo (orforglipron)
Eli Lilly · Weight loss (FDA-approved April 2026, oral GLP-1 pill)
Source: Foundayo Coverage & Savings
Rybelsus (oral semaglutide)
Novo Nordisk · Type 2 diabetes
Source: NovoCare Rybelsus
Saxenda (liraglutide — daily injection for weight loss)
Included for completeness: Novo ended the Saxenda savings program years ago, so there’s no active $25 path. If your plan covers it, you pay your plan’s standard specialty copay. In 2026, most patients will land on Wegovy, Zepbound, or Foundayo as better answers.
So Which Route Is Cheapest for You Specifically?
If you already have an in-network PCP or endocrinologist
Ask your doctor at your next visit whether they’ll prescribe Wegovy, Zepbound, or Foundayo (for weight loss) or Ozempic, Mounjaro, or Rybelsus (for type 2 diabetes). If they’ll write a script for one your plan covers, your drug cost can land at $25 and your only additional cost is whatever your plan asks for at the office. You don’t need any telehealth platform.
Two things to bring to the appointment to speed up approval:
- Your insurance card plus a quick coverage check (call the number on the back and ask: “Do you cover [drug name] for [indication]? Is prior authorization required? What’s the formulary tier?”).
- Weight history, BMI documentation, and notes on any comorbidities — high blood pressure, high cholesterol, sleep apnea, prediabetes — that strengthen the prior auth.
If you don’t have a doctor or your PA is already stuck
The practical flow:
- Run Ro’s free GLP-1 Insurance Coverage Checker — it’s free. Enter your insurance info, Ro contacts your insurer, and you receive a personalized report showing which GLP-1s your plan covers, whether PA is required, and your estimated copay per drug.
- If your plan covers a GLP-1 and you want Ro to handle prescribing and PA: join Ro Body at $39 first month, then $149/month (or as low as $74/month with annual prepay). Ro’s insurance concierge files the PA paperwork on your behalf. Ro reports that commercial insurance setup typically takes 1–3 weeks from signup to first fill.
- If your plan denies coverage but you still want FDA-approved brand medication, Ro offers Wegovy pill at $149/month first then $199–$299, Wegovy pen at $199/month first then $199–$349, Zepbound KwikPen at $299/month first then $399–$449, and Foundayo at $149/month first then $199–$299 — all matching LillyDirect and NovoCare Pharmacy pricing.
If you want the lowest membership fee (and you’re willing to commit)
Consider WeightWatchers Med+ (free cost estimator, $25/month intro for 2 months then $74/month on a 12-month plan) or PlushCare ($19.99/month membership plus per-visit copays). Both accept insurance and your drug cost can land at the same $25 floor if your plan covers the drug. Neither is our direct affiliate partner — we’re including them because the honest cheapest answer matters more than our commission.
If you want an obesity-specialist program billed through insurance
Form Health is worth a look. Form Health is a telehealth obesity care provider that bills clinician visits, lab tests, and medications through most major private insurance and Medicare (you pay your plan’s cost-sharing). Self-pay is $299/month if your plan doesn’t cover their program. Form Health is not one of our affiliate partners — we’re including it because on an insurance-first query, leaving it out would be dishonest.
If you have Medicare or Medicaid
Different rules entirely — manufacturer savings cards are excluded for government beneficiaries by federal law. Your path is the Medicare GLP-1 Bridge (launching July 1, 2026) or your state’s Medicaid formulary. See the Medicare/Medicaid section below.
If your insurance already denied you
See the “What If Your Insurance Says No?” section below for the three paths forward.
How the $25/Month Floor Actually Works (And When It Breaks)
The $25 number is two discounts stacked on top of each other. Your commercial insurance pays the bulk of the drug’s list price. The manufacturer’s savings card covers most of what’s left. If your plan’s copay is $100 or less, the card brings you to $25. If your plan’s copay is $400, the card can’t close the full gap — you’ll land somewhere around $300.
Layer 1: Your insurance
A GLP-1’s list price is typically $1,000–$1,800/month. Your plan pays the bulk of that. You’re left owing a copay, coinsurance, or deductible depending on your plan’s specialty tier.
Layer 2: The savings card
The card pays down most of your remaining out-of-pocket cost, capped at $100/month for Wegovy, Zepbound, Ozempic, Foundayo, and Rybelsus, or $150/month for Mounjaro. If your copay is already under $25, the card doesn’t help.
The four scenarios where $25 breaks
Activation — three minutes, one time
- Confirm you have commercial (not government) insurance.
- Go to the manufacturer’s savings page:
- Enter your info, get the digital card, add it to Apple or Google Wallet.
- Hand it to the pharmacist with your prescription. They run it as a secondary payer after your insurance.
- If the discount doesn’t apply at the counter, two questions: “Did you run my insurance as primary?” and “Does my plan actually cover this drug?”
What If Your Insurance Says No? Three Paths Forward
Per Ro’s 2025 Coverage Checker Report, 43% of people who ran a check had commercial coverage for a GLP-1 for weight loss. Coverage for diabetes indications is far more common. If your plan excluded or denied your GLP-1, you have three real paths forward.
Path 1: Appeal the denial
Many prior-authorization denials can be overturned on appeal with proper documentation. An appeal packet typically needs:
- Your denial letter (shows the exact reason code)
- Documented BMI history from your EMR
- Documentation of comorbidities (hypertension, hyperlipidemia, T2D, sleep apnea, cardiovascular disease)
- Documented prior weight-loss attempts — diet and exercise programs, prior anti-obesity medication trials
- A letter of medical necessity from your prescriber
Path 2: Switch to a covered drug
Your plan probably covers a GLP-1 even if it doesn’t cover your first choice. Real example from 2025: CVS Caremark stopped covering Zepbound and directed patients to Wegovy instead. Same outcome category, different drug, coverage restored, copay back to $25. Before committing to cash-pay, ask your plan: “Which GLP-1s are on my formulary?”
Path 3: Cash-pay through an FDA-approved program
If your plan flat-out excludes weight-loss GLP-1s, the cheapest FDA-approved fallbacks are:
Foundayo (oral)
$149/month starter dose through Lilly
Wegovy pill
$149/month starter doses through NovoCare Pharmacy (through Aug 31, 2026)
Wegovy pen
$199/month first two fills for new patients (through June 30, 2026), then $349/month
Zepbound KwikPen
$299–$449/month through LillyDirect
Ro offers all of these at the same prices as LillyDirect, NovoCare Pharmacy, and TrumpRx — matching manufacturer direct pricing — with the Ro Body membership added ($39 first month, $149/month ongoing, or as low as $74/month with annual prepay). Sesame Care sells branded GLP-1s across the widest formulary (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, Saxenda) with Costco-member pricing on Wegovy and Ozempic.
The Prior Authorization Checklist: 11 Items That Predict Approval
Prior authorization is the single biggest blocker to getting a GLP-1 covered. This checklist reflects the criteria commonly requested by major commercial health plans and pharmacy benefit managers. Print it. Bring it to your next appointment. Hand it to your doctor’s office.
- 1Documented BMI: Most plans require BMI ≥30, or BMI ≥27 with a weight-related comorbidity.
- 2Documented comorbidity (if BMI is 27–29.9): Commonly accepted: type 2 diabetes, hypertension, hyperlipidemia, obstructive sleep apnea, established cardiovascular disease.
- 3Recent weight history: 6+ months of documented weight in EMR records is often requested.
- 4Prior lifestyle intervention documented: Evidence of 3–6 months of a supervised diet and/or exercise program that didn't produce sustained weight loss.
- 5Prior medication trial (if step therapy applies): Some plans require trial and failure of older anti-obesity drugs before approving a GLP-1. Documentation of trial and failure or intolerance is needed.
- 6FDA-approved indication matches the diagnosis: For weight loss: Wegovy, Zepbound, Foundayo, Saxenda. For type 2 diabetes: Ozempic, Mounjaro, Rybelsus. Off-label prescribing gets denied far more often.
- 7Letter of medical necessity: From your prescribing provider. Should explain why this specific drug over a cheaper alternative.
- 8Baseline labs: A1C, lipid panel, and renal function are commonly requested.
- 9No listed contraindications: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Pancreatitis history is a common review point.
- 10Treatment plan: Dose titration schedule, follow-up cadence, and a weight-loss goal. Plans often require documented progress at reauthorization.
- 11Correct dispensing pharmacy: Some plans require fills through designated specialty pharmacies; filling elsewhere can trigger a denial.
What Changes If You Have Medicare or Medicaid?
Medicare: The GLP-1 Bridge launches July 1, 2026
Announced by CMS in December 2025 and detailed in a March 2026 FAQ, the Medicare GLP-1 Bridge is a short-term demonstration running July 1, 2026 through December 31, 2026 that lets eligible Medicare Part D beneficiaries access specific GLP-1 drugs at a $50/month copay for weight-loss indications. A CMS central processor handles prior authorization and claims — Part D plans don’t administer it.
Covered drugs for the Bridge
- Wegovy: All formulations (injection and tablets)
- Zepbound: KwikPen formulation ONLY — single-dose vials/pens NOT included
- Foundayo: All formulations (added April 6, 2026)
Eligibility criteria (must meet one of three)
- Tier 1: BMI ≥35 alone
- Tier 2: BMI ≥30 with heart failure with preserved ejection fraction, uncontrolled hypertension on two antihypertensives, or CKD stage 3a+
- Tier 3: BMI ≥27 with pre-diabetes (ADA guidelines), prior MI, prior stroke, or symptomatic peripheral artery disease
Source: CMS Medicare GLP-1 Bridge
Medicaid: 13 states cover GLP-1s for obesity as of January 2026
Per the Kaiser Family Foundation’s January 2026 Medicaid GLP-1 tracker, 13 state Medicaid fee-for-service programs cover GLP-1 medications for obesity treatment — down from previous years as California, New Hampshire, Pennsylvania, and South Carolina ended weight-loss GLP-1 coverage effective January 1, 2026. T2D coverage under Medicaid remains widely available. For weight-loss indications, check your state’s Medicaid formulary directly — rules are changing quarterly.
The employer-plan context
Why We Don’t Recommend Compounded GLP-1s on This Page
This is an insurance-first query, which means we’re talking about drugs your insurance can actually pay for — and insurance only covers FDA-approved drugs.
There are legitimate reasons to consider compounded GLP-1s — primarily cost, for patients whose insurance denies coverage and who can’t afford $149–$499/month cash-pay. We cover that intent on a separate page: GLP-1 options under $200/month. But on a page titled “cheapest GLP-1 with insurance,” featuring compounded providers as winners would be dishonest — and would also fail most readers, because compounded can’t stack with insurance.
What Real Patients Say About Getting Covered
“I could have gone with anyone else, but Ro just spoke to me. It felt like, ‘We’re here for you.’ I initially thought I had to pay $1,000 for my medication so I sat on starting my journey for a couple of months. I decided to reach out to Ro to see if the medication cost could be lowered. Within two days, Ro ran my prior authorization and guided me to a savings card. When I went to CVS to pick up my prescription, it was just $25.”
Disclosure: Weight Loss Provider Guide has an affiliate relationship with Ro. This testimonial is a paid patient testimonial as disclosed by Ro on its own report page. Individual experiences vary. The testimonial describes coverage and service navigation experience only — it does not imply typical clinical results, weight-loss outcomes, or medical efficacy.
How We Verified This (And What We Couldn’t)
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. For this page:
- Every price cell in the cost table was pulled from the manufacturer’s own pages or the provider’s own pricing page as of April 21, 2026.
- Medicare GLP-1 Bridge details pulled from CMS.gov’s Medicare GLP-1 Bridge page, last CMS update April 6, 2026.
- Medicaid state coverage data from the Kaiser Family Foundation’s January 2026 tracker.
- Employer coverage rates from Peterson-KFF Health System Tracker (2025 data).
- Ro Coverage Checker statistics (43% with GLP-1 coverage for weight loss; near-universal T2D coverage) from Ro’s published 2025 Coverage Checker Report covering user data from August 13, 2024 through April 17, 2025.
Who we are: Our payout from Ro is a small fraction of what other partners pay us — we lead with Ro on this page because it’s the right recommendation for commercially insured shoppers, not because it’s the most profitable one.
Frequently Asked Questions
Still Not Sure Which GLP-1 Path Is Right for You?
If the decision branches above didn’t fully resolve your situation — maybe your plan is complicated, maybe you’re between Medicare-eligible and commercial, maybe you’re weighing cash-pay against appealing a denial — we built a short quiz that routes you to the specific next step based on your exact situation.
Find your cheapest GLP-1 path in 60 seconds
Our quiz asks about your insurance type, whether you have a prescriber, and your budget priority — then outputs the specific path (and provider) that fits your situation.
Take the free Find My GLP-1 Path quizIf you already know you want the FDA-approved brand-name insurance path and you don’t have a prescribing doctor in hand, Ro’s free coverage check is the fastest way to learn what your plan actually covers before you commit to anything:
Related guides
- GLP-1 side effects: what's normal vs. ER-worthy (2026 triage guide)
- How to report a bad GLP-1 experience to FDA MedWatch
- GLP-1 SOS: instant relief for nausea, constipation, and injection-site pain
- Best GLP-1 providers compared: Ro, Sesame, Form Health, and more
- GLP-1 pros and cons: the honest 2026 breakdown
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. Advertising disclosure. Editorial standards.
Last verified against manufacturer and CMS sources: April 21, 2026. Manufacturer savings card terms renew annually; the 2026 terms referenced here expire December 31, 2026 for Lilly cards. Next scheduled full review: July 2026, or immediately when CMS issues new Medicare GLP-1 coverage guidance.
This content is for informational purposes only and is not medical advice. Talk with a licensed healthcare provider about whether a GLP-1 medication is appropriate for you, which specific drug fits your medical history, and how to manage side effects and contraindications. Individual experiences with insurance coverage and GLP-1 treatment vary.